The Effects of Polyphenol-rich Berry Juice on Blood Pressure in Hypertensive Subjects
Launched by UNIVERSITY OF OSLO · Mar 29, 2012
Trial Information
Current as of May 08, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pre-hypertension or hypertension systolic blood pressure in the 130-179 mmHg range and/or diastolic blood pressure in the 85-109 mmHg range)
- • BMI 20-35 kg/m2
- • Stable weight (change \<4 kg previous 12 weeks)
- Exclusion Criteria:
- • Regular use of blood pressure lowering agens
- • Diabetes type I or II
- • Smokers
- • Allergy to grape, cherries, blueberries/bilberries, black currant, aronia
- • Supplements for weight loss
- • Changes in pharmacological treatment of hyperlipidemia or hyperglycemia (initiation, termination or changes in dosage) last 30 days prior to inclusion or during the study period (run-in and intervention)
- • Participation in a drug trial during the previous 30 days
About University Of Oslo
The University of Oslo, a leading research institution in Norway, is dedicated to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration and ethical research practices, the university harnesses its extensive expertise in various fields, including medicine, health sciences, and biomedical research. The University of Oslo actively engages in clinical trials aimed at exploring new therapies and interventions, fostering a culture of scientific inquiry, and contributing to the global understanding of health and disease. Through its commitment to excellence and rigorous methodologies, the university seeks to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Oslo, , Norway
Patients applied
Trial Officials
Rune Blomhoff, PhD
Principal Investigator
University of Oslo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials